We are live on ! Find out more
SA

Sicart Associates Portfolio holdings

AUM $389M
1-Year Est. Return 42.46%
This Fund
S&P 500
This Quarter Est. Return
+4.6%
1 Year Est. Return
+42.46%
3 Year Est. Return
+89.06%
5 Year Est. Return
+118.65%
10 Year Est. Return
AUM
$386M
AUM Growth
+$3.33M
Cap. Flow
-$6.99M
Cap. Flow %
-1.81%
Top 10 Hldgs %
45.26%
Holding
107
New
5
Increased
13
Reduced
51
Closed
10

Top Buys

Rank Stock Value
1
PYPL icon
PayPal
PYPL
+$10.7M
2
GH icon
Guardant Health
GH
+$6.28M
3
NFLX icon
Netflix
NFLX
+$5.46M
4
META icon
Meta Platforms (Facebook)
META
+$5.06M
5
ZM icon
Zoom
ZM
+$4.52M

Sector Composition

Rank Sector Weight
1 Healthcare 16.8%
2 Consumer Staples 16.15%
3 Materials 15.32%
4 Communication Services 9.15%
5 Technology 8.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IWM icon
101
iShares Russell 2000 ETF
IWM
$83.2B
-966
Closed -$215K
KBR icon
102
KBR
KBR
$4.72B
-10,096
Closed -$476K
PRU icon
103
Prudential Financial
PRU
$43.9B
-6,415
Closed -$697K
SILJ icon
104
Amplify Junior Silver Miners ETF
SILJ
$3.64B
-10,250
Closed -$127K
WAB icon
105
Wabtec
WAB
$50.5B
-4,995
Closed -$459K
CTXS
106
DELISTED
Citrix Systems Inc
CTXS
-4,230
Closed -$405K
KOR
107
DELISTED
Corvus Gold Inc. Common Shares
KOR
-21,500
Closed -$68K

Similar funds

Sicart Associates's Q1 2022 Portfolio in Review

As of Q1 2022, Sicart Associates held 107 positions worth $386M, up 0.87% from $383M the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Sicart Associates's Q1 2022 filing shows 5 new, 13 increased, 51 reduced and 10 closed positions. Its largest new stake was PayPal: 80,360 shares worth $9.29M. The largest sale was Pfizer, an estimated $12.9M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 23% a quarter earlier, followed by Consumer Staples and Materials.

  • Sicart Associates's largest Q1 2022 buy was PayPal: 80,360 shares worth $9.29M.
  • Sicart Associates added most to Guardant Health in Q1 2022, an estimated $6.28M increase.
  • Sicart Associates's biggest Q1 2022 reduction was Pfizer, cutting an estimated $12.9M.
  • Sicart Associates fully exited Prudential Financial in Q1 2022, selling an estimated $697K.
  • Sicart Associates's ten largest holdings make up 45% of its $386M portfolio in Q1 2022.
  • Sicart Associates opened 5 new positions and closed 10 in Q1 2022.
  • Sicart Associates's portfolio value rose 0.87% quarter-over-quarter to $386M.

Based on Sicart Associates's 13F filing for Q1 2022, filed 6 May 2022.